For those who love a 'Falling Wedge' !! Skinbiotherapeutics also has good data and ratings to support this 'Bullish reversal pattern'...
Long
SkinBioTherapeutics Plc
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.00 GBP
−696.25 K GBP
4.64 M GBP
142.09 M
About SkinBioTherapeutics Plc
Sector
Industry
CEO
Stuart John Ashman
Website
Headquarters
Newcastle-upon-Tyne
Founded
2015
IPO date
Apr 5, 2017
Identifiers
2
ISIN GB00BF33H870
SkinBioTherapeutics Plc is a life science company, which focuses on skin health. It offers SkinBiotix, a technology platform based on microbiome research which comprises extracts of probiotic bacteria for skin application. The technology targets the following skin healthcare sectors: cosmetics, infection control, and eczema. The company was founded on June 10, 2015 is headquartered in Newcastle upon Tyne, the United Kingdom.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SBTX is 12.40 GBX — it has decreased by −36.54% in the past 24 hours. Watch SkinBioTherapeutics Plc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange SkinBioTherapeutics Plc stocks are traded under the ticker SBTX.
SBTX stock has fallen by −41.07% compared to the previous week, the month change is a −34.00% fall, over the last year SkinBioTherapeutics Plc has showed a −33.11% decrease.
We've gathered analysts' opinions on SkinBioTherapeutics Plc future price: according to them, SBTX price has a max estimate of 29.00 GBX and a min estimate of 29.00 GBX. Watch SBTX chart and read a more detailed SkinBioTherapeutics Plc stock forecast: see what analysts think of SkinBioTherapeutics Plc and suggest that you do with its stocks.
SBTX reached its all-time high on May 26, 2021 with the price of 88.00 GBX, and its all-time low was 5.00 GBX and was reached on Mar 27, 2020. View more price dynamics on SBTX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SBTX stock is 60.71% volatile and has beta coefficient of 0.91. Track SkinBioTherapeutics Plc stock price on the chart and check out the list of the most volatile stocks — is SkinBioTherapeutics Plc there?
Yes, you can track SkinBioTherapeutics Plc financials in yearly and quarterly reports right on TradingView.
SkinBioTherapeutics Plc is going to release the next earnings report on Mar 31, 2026. Keep track of upcoming events with our Earnings Calendar.
SBTX net income for the last half-year is 337.85 K GBP, while the previous report showed −1.03 M GBP of net income which accounts for 132.67% change. Track more SkinBioTherapeutics Plc financial stats to get the full picture.
No, SBTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 14, 2026, the company has 41 employees. See our rating of the largest employees — is SkinBioTherapeutics Plc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SkinBioTherapeutics Plc EBITDA is −723.39 K GBP, and current EBITDA margin is −9.21%. See more stats in SkinBioTherapeutics Plc financial statements.
Like other stocks, SBTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SkinBioTherapeutics Plc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SkinBioTherapeutics Plc technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SkinBioTherapeutics Plc stock shows the strong sell signal. See more of SkinBioTherapeutics Plc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.